Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Breast Cancer Research : BCR|March 2, 2013
Contralateral breast cancer risk in BRCA1/2-positive families needs to be adjusted for phenocopy rates particularly in second-degree untested relativesD Gareth R Evans, Anthony Howell, Sarah L Ingham, et al.BMC Medical Research Methodology|June 23, 2010
Development and validation of self-reported line drawings for assessment of knee malalignment and foot rotation: a cross-sectional comparative studySarah L Ingham, Amanda Moody, Abhishek Abhishek, et al.BMC Medical Informatics and Decision Making|October 3, 2014
Can multiple SNP testing in BRCA2 and BRCA1 female carriers be used to improve risk prediction models in conjunction with clinical assessment?Mattia C F Prosperi, Sarah L Ingham, Anthony Howell, et al.Annals of the Rheumatic Diseases|May 27, 2011
Nottingham knee osteoarthritis risk prediction modelsWeiya Zhang, Daniel F McWilliams, Sarah L Ingham, et al.Breast Cancer Research and Treatment|June 21, 2013
Contralateral mastectomy improves survival in women with BRCA1/2-associated breast cancerD Gareth R Evans, Sarah L Ingham, Andrew Baildam, et al.Breast Cancer Research and Treatment|November 20, 2013
Risk-reducing surgery increases survival in BRCA1/2 mutation carriers unaffected at time of family referralSarah L Ingham, Matthew Sperrin, Andrew Baildam, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 29, 2013
Increased rate of phenocopies in all age groups in BRCA1/BRCA2 mutation kindred, but increased prospective breast cancer risk is confined to BRCA2 mutation carriersD Gareth R Evans, Sarah L Ingham, Iain Buchan, et al.European Journal of Human Genetics : EJHG|June 23, 2011
Mortality in neurofibromatosis 1: in North West England: an assessment of actuarial survival in a region of the UK since 1989D Gareth R Evans, Catherine O'Hara, Anna Wilding, et al.Pageof 1